Skip to main content

All oral evidence

A session is a parliamentary year. Sessions normally begin in the Spring with the State Opening of Parliament and run for about 12 months. There are normally five sessions in each Parliament.

24 February 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Anthony Harnden (Deputy Chair, Joint Committee on Vaccination and Immunisation and Professor of Primary Care at University of Oxford), Professor Wendy Barclay (Head of the Department of Infectious Disease at Imperial College London), Dr Philip Dormitzer (Vice President and Chief Scientific Officer of Viral Vaccines at Pfizer), Professor Sarah Gilbert (Professor of Vaccinology at University of Oxford), Madelaine McTernan (Director General at UK Vaccine Taskforce), and Nadhim Zahawi (Minister for COVID Vaccine Deployment at Department for Health and Social Care)
Committees Science and Technology Committee (Commons)
OralEvidence
17 February 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Dame Angela McLean (Professor of Mathematical Biology at University of Oxford, and Chief Scientific Adviser at Ministry of Defence), Professor Mark Woolhouse OBE (Professor of Infectious Disease Epidemiology at University of Edinburgh), Dr James Rubin (Professor of Psychology & Emerging Health Risks at Kings College London), Professor Sir John Bell (Regius Professor of Medicine at Oxford University), James Hetherington (Chief Data Science Adviser at Joint Biosecurity Centre), and Dr Johanna Hutchinson (Director for Data and Data Science at Joint Biosecurity Centre)
Committees Science and Technology Committee (Commons)
OralEvidence
3 February 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Baroness Harding of Winscombe (Interim Executive Chair at National Institute for Health Protection), Mark Hewlett (Director of Testing at NHS Test and Trace), and Steve McManus (Director of Tracing at NHS Test and Trace)
Committees Science and Technology Committee (Commons)
OralEvidence
27 January 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Greg Fell (Director of Public Health at Sheffield City Council), and Dr Richard Harling MBE (Director of Health and Care at Staffordshire County Council)
Committees Science and Technology Committee (Commons)
OralEvidence
26 January 2021
Inquiry Coronavirus: lessons learnt
Committees Science and Technology Committee (Commons), and Health and Social Care Committee
OralEvidence
13 January 2021
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Wei Shen Lim (Chair, Covid-19 Immunisation at Joint Committee on Vaccination and Immunisation), Dr Mary Ramsay (Head of Immunisation at Public Health England), Sir Mene Pangalos (Executive Vice President of BioPharmaceuticals Research and Development at AstraZeneca), Tom Keith-Roach (President at AstraZeneca UK), Nadhim Zahawi (Minister for COVID Vaccine Deployment at Department for Health and Social Care), and Antonia Williams (Director (Covid Vaccines) at Department for Health and Social Care)
Committees Science and Technology Committee (Commons)
OralEvidence
23 December 2020
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Neil Ferguson OBE (Director at MRC Centre for Global Infectious Disease Analysis at Imperial College London), Professor Peter Horby (Chair at New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG)), and Professor Wendy Barclay (Head of the Department of Infectious Disease at Imperial College London)
Committees Science and Technology Committee (Commons)
OralEvidence
9 December 2020
Inquiry Coronavirus: lessons learnt
Witnesses Sir Patrick Vallance, Government Chief Scientific Adviser, Professor Chris Whitty, Chief Medical Officer for England, Dr Jenny Harries (Deputy Chief Medical Officer at Department for Health and Social Care), and Dr June Raine (Chief Executive at Medicines and Healthcare products Regulatory Agency (MHRA))
Committees Science and Technology Committee (Commons), and Health and Social Care Committee
OralEvidence
2 December 2020
Inquiry Coronavirus: lessons learnt
Witnesses Professor Dame Sally Davies, Chief Medical Officer for England (2010-2019), Sir Mark Walport, Government Chief Scientific Adviser (2013-2017), Sir Oliver Letwin, Cabinet Office Minister (2010-2016), and Lord Mark Sedwill, Cabinet Secretary (2018-2020)
Committees Science and Technology Committee (Commons), and Health and Social Care Committee
OralEvidence
1 December 2020
Inquiry Coronavirus: lessons learnt
Committees Science and Technology Committee (Commons), and Health and Social Care Committee
OralEvidence
24 November 2020
Inquiry Coronavirus: lessons learnt
Committees Science and Technology Committee (Commons), and Health and Social Care Committee
OralEvidence
22 July 2020
Inquiry UK telecommunications infrastructure and the UK’s domestic capability
Witnesses Amy Karam (Global Strategist and Fellow at Canadian Global Affairs Institute), Dr Dritan Kaleshi (Head of Technology (5G) at Digital Catapult), and Oliver Dowden (Secretary of State for Digital, Culture, Media and Sport at Department for Digital, Culture, Media and Sport)
Committees Science and Technology Committee (Commons)
OralEvidence
11 November 2020
Inquiry A new UK research funding agency
Witnesses Sir John Kingman (Chair at UK Research and Innovation (UKRI)), Professor Dame Ottoline Leyser (Chief Executive at UK Research and Innovation (UKRI)), Amanda Solloway (Minister for Science, Research and Innovation at Department for Business, Energy and Industrial Strategy), and Sarah Hodgetts (Deputy Director for UKRI Sponsorship and Advanced Research Projects Agency at Department for Business, Energy and Industrial Strategy)
Committees Science and Technology Committee (Commons)
OralEvidence
10 November 2020
Inquiry Coronavirus: lessons learnt
Committees Science and Technology Committee (Commons), and Health and Social Care Committee
OralEvidence
4 November 2020
Inquiry Coronavirus: lessons learnt
Witnesses Professor Peter Horby (Professor of Emerging Infectious Diseases and Global Health at University of Oxford), Professor Andrew Pollard (Trial Chief Investigator at University of Oxford), Professor Robin Shattock (Chair in Mucosal Infection and Immunity at Imperial College London), Professor Wei Shen Lim (Chair, COVID-19 Panel at Joint Committee on Vaccination and Immunisation), and Kate Bingham (Chair at UK Vaccine Taskforce)
Committees Science and Technology Committee (Commons), and Health and Social Care Committee
OralEvidence
3 November 2020
Inquiry UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks
Witnesses Professor Chris Whitty, Chief Medical Officer for England, and Sir Patrick Vallance, Government Chief Scientific Adviser
Committees Science and Technology Committee (Commons)
OralEvidence
28 October 2020
Inquiry UK telecommunications infrastructure and the UK’s domestic capability
Witnesses Lord Livingston of Parkhead (Chair at Telecoms Diversification Taskforce), Scott Bailey (Deputy Director of the Diversification Unit at Department for Digital, Culture, Media and Sport), Tareq Amin (Chief Technology Officer at Rakuten Mobile), Dr Tobias Feakin (Ambassador for Cyber Affairs and Critical Technology at Australian Government), Dr Ian Levy (Technical Director at National Cyber Security Centre), and Dr Yih-Choung Teh (Group Director for Strategy and Research at Ofcom)
Committees Science and Technology Committee (Commons)
OralEvidence
21 October 2020
Inquiry Coronavirus: lessons learnt
Witnesses Dr Max Roser (Director at Oxford Martin Programme on Global Development), Professor David Heymann (Professor of Infectious Disease Epidemiology at London School of Hygiene and Tropical Medicine), Professor Mark Woolhouse OBE (Professor of Infectious Disease Epidemiology at University of Edinburgh), Professor John Edmunds OBE (Professor at London School of Hygiene and Tropical Medicine), Sir Ian Diamond (National Statistician at Office of National Statistics), Professor Axel Gandy (Chair in Statistics at Imperial College London), and Dr Clare Gardiner (Director at Joint Biosecurity Centre)
Committees Science and Technology Committee (Commons), and Health and Social Care Committee
OralEvidence
13 October 2020
Inquiry Coronavirus: lessons learnt
Committees Science and Technology Committee (Commons), and Health and Social Care Committee
OralEvidence
23 September 2020
Inquiry A new UK research funding agency
Witnesses William Bonvillian (Lecturer at Massachusetts Institute of Technology), Dr Peter Highnam (Deputy Director at Defense Advanced Research Projects Agency), Dr Regina Dugan (Chief Executive Officer at Wellcome Leap), and Dr Antoine Petit (Chairman and CEO at French National Centre for Scientific Research (CNRS))
Committees Science and Technology Committee (Commons)
OralEvidence
Total results 43 (page 1 of 3)